Lisa F Schneider1, Michelle P Warren. 1. Department of Obstetrics and Gynecology and Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA. ls2086@columbia.edu <ls2086@columbia.edu>
Abstract
OBJECTIVE: To determine whether ghrelin, an orexigen released by the stomach, is elevated in women with hypothalamic amenorrhea who are of normal weight and whether this is associated with abnormal eating behaviors. DESIGN: Controlled clinical study. SETTING:Healthy volunteers in an academic research environment. PATIENT(S): Twenty-seven women with functional hypothalamic amenorrhea (FHA) and 42 normally menstruating women. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Ghrelin and eating behavior. RESULT(S): Ghrelin was significantly elevated in FHA (648.4 +/- 92.0 pg/mL vs. controls 596.7 +/- 79.0 pg/mL), while leptin, although lower, was not significantly so (FHA 5.4 +/- 2.8 ng/mL vs. controls 6.4 +/- 3 ng/mL). Eating Attitudes Test (EAT) scores were also significantly elevated in FHA (15.3 +/- 10.6 vs. controls 10.3 +/- 8.4), particularly on the subscale that measured bulimic behaviors. However, FHA patients consumed significantly more kilocalories (1,930 kcal/day vs. 1,588 kcal/day). CONCLUSION(S): High ghrelin in women with FHA may be linked to abnormal dietary behaviors, as reflected in high EAT scores yet characterized by normal caloric intake. Ghrelin may act as a restraining metabolic signal preventing a return to cyclicity in women with both disordered eating and FHA, prolonging amenorrhea when leptin has returned to normal.
RCT Entities:
OBJECTIVE: To determine whether ghrelin, an orexigen released by the stomach, is elevated in women with hypothalamic amenorrhea who are of normal weight and whether this is associated with abnormal eating behaviors. DESIGN: Controlled clinical study. SETTING: Healthy volunteers in an academic research environment. PATIENT(S): Twenty-seven women with functional hypothalamic amenorrhea (FHA) and 42 normally menstruating women. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Ghrelin and eating behavior. RESULT(S): Ghrelin was significantly elevated in FHA (648.4 +/- 92.0 pg/mL vs. controls 596.7 +/- 79.0 pg/mL), while leptin, although lower, was not significantly so (FHA 5.4 +/- 2.8 ng/mL vs. controls 6.4 +/- 3 ng/mL). Eating Attitudes Test (EAT) scores were also significantly elevated in FHA (15.3 +/- 10.6 vs. controls 10.3 +/- 8.4), particularly on the subscale that measured bulimic behaviors. However, FHApatients consumed significantly more kilocalories (1,930 kcal/day vs. 1,588 kcal/day). CONCLUSION(S): High ghrelin in women with FHA may be linked to abnormal dietary behaviors, as reflected in high EAT scores yet characterized by normal caloric intake. Ghrelin may act as a restraining metabolic signal preventing a return to cyclicity in women with both disordered eating and FHA, prolonging amenorrhea when leptin has returned to normal.
Authors: Elizabeth A Lawson; Kamryn T Eddy; Daniel Donoho; Madhusmita Misra; Karen K Miller; Erinne Meenaghan; Janet Lydecker; David Herzog; Anne Klibanski Journal: Eur J Endocrinol Date: 2010-11-23 Impact factor: 6.664
Authors: B Meczekalski; K Katulski; A Czyzyk; A Podfigurna-Stopa; M Maciejewska-Jeske Journal: J Endocrinol Invest Date: 2014-09-09 Impact factor: 4.256